GOLPH3 is expressed in both the prostate and metastatic lymph nodes, with higher expression in the metastatic lymph nodes (however, this difference was not statistically significant, p=0.056) and a positive correlation between GOLPH3 expression levels in the prostate and metastatic lymph nodes, suggesting a potential connection between primary and metastatic tumors. Here, GOLPH3 is linked to metastatic neoplasm.